Spago Nanomedical
Spago Nanomedical presents at Redeye’s Fight Cancer event on January 24
Spago Nanomedical AB (publ) announced today that the company will participate at Redeye’s Fight Cancer event on January 24, 2024. At the event, Spago Nanomedical’s CEO Mats Hansen will give an update on the company’s radiopharma program Tumorad® and participate in a panel discussion on precision medicine.
The presentation and panel discussion are broadcasted live via Redeye’s website https://www.redeye.se/events/966280/redeye-theme-fight-cancer-2?tab=schedule
The presentation will also be available at Spago Nanomedical’s website afterwards at https://spagonanomedical.se/media/
Location: Redeye, Mäster Samuelsgatan 42, Stockholm
Presentation time: Wednesday, January 24 at 16:28
Event hours: 09:00 AM - 05:00 PM
Datum | 2024-01-18, kl 08:00 |
Källa | MFN |
![](https://static.allaaktier.se/ads/hand-waving-2.png)